Secretion of CXCL9 and CXCL10 by myeloid cells is critical for CTL recruitment and tumor control after adoptive T cell transfer or ICB treatment.31–33 Absolute quantification of F4/80+ monocytic macrophage (MoMac) or DCs showed no change in YUMM3.3-βΑ compared with YUMM3.3-Ctrl tumors, and proportions of MoMac subtypes were comparable between the two groups (figure 5L and M). This evidence concerns the gene CXCL10 and neoplasm.